TENX
TENAX THERAPEUTICS, INC.
NASDAQ · Healthcare · Biotechnology · US
$1.81
−1.63%Price chart
Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4
Key dataNov 4, 2026
Open$1.85
From 52W high−90.12%
Volume1.24M
Market cap$67.74M
P/E (TTM)—
P/S (TTM)—
Div yield—
Key dataNov 4, 2026
Open
$1.85
From 52W high
−90.12%
Volume
1.24M
Market cap
$67.74M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
0.8x
P/E (TTM)
—
RSI (14)
43.8
MomentumView details →
1D Return
−1.63%
YTD Return
−85.56%
SummaryUpdated Jun 1, 2026
Tenax Therapeutics, Inc. (NASDAQ:TENX) is a specialty pharmaceutical company founded in 1967 and headquartered in Morrisville, North Carolina. Originally known as Oxygen Biotherapeutics, Inc., the company rebranded to Tenax Therapeutics in September 2014 to reflect its focus on developing treatments for cardiovascular and pulmonary diseases. The company has been publicly traded since 1994 and operates as a clinical-stage biopharmaceutical company with no current revenue-generating products, focusing entirely on drug development and clinical trials.
Similar companies
Latest newsMore news →
Law Offices of Howard G. Smith announced that it is investigating whether Tenax Therapeutics violated federal securities laws.5d agoA class action lawsuit was filed against Tenax Therapeutics on behalf of investors who acquired its securities between November 13, 2023 and August 7, 2026.6d agoLaw Offices of Frank R. Cruz announced an investigation into potential securities fraud claims involving TENAX THERAPEUTICS, INC.6d ago